- Home
- THRD
as 04-25-2025 4:00pm EST
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 164.2M | IPO Year: | 2022 |
| Target Price: | $5.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.18 - $16.94 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Third Harmonic Bio Inc. News
THRD Breaking Stock News: Dive into THRD Ticker-Specific Updates for Smart Investing
MT Newswires
12 days ago
Sector Update: Health Care Stocks Rise Pre-Bell Monday
MT Newswires
12 days ago
Top Premarket Gainers
BioPharma Dive
12 days ago
Third Harmonic outlines plans for dissolution
MT Newswires
12 days ago
Third Harmonic Seeks to Liquidate, Dissolve Company
GlobeNewswire
12 days ago
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
MT Newswires
a month ago
Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23
GlobeNewswire
a month ago
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Zacks
2 months ago
Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Compare THRD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "THRD Third Harmonic Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.